A medical technology company focused on ear, nose, and throat treatments, best known for developing drug‑eluting implants used in sinus surgery to maintain sinus openings and deliver localized anti‑inflammatory medication. Its product portfolio targeted chronic sinusitis and postoperative care for E...
1 member of Congress has disclosed 1 trade in Intersect ENT, Inc. (XENT), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-03-06 | Donna Shalala | buy | $1K – $15K |